WIPO stalemate: No agreement reached on genetic resources, traditional knowledge and folklore
*The author thanks Professor Marc Perlman (Brown University) for his comprehensive notes on the IGC deliberations.
*The author thanks Professor Marc Perlman (Brown University) for his comprehensive notes on the IGC deliberations.
Pope Benedict XVI today issued a statement saying that “On the part of rich countries, there is excessive zeal for protecting knowledge through an unduly rigid assertion of the right to intellectual property, especially in the field of health care.” The criticism came in a section of his most recent encyclical letter dealing with social issues, and specifically focusing on international human development and systemic failures of bodies large and small to solve development problems.
TACD has issued a resolution on copyright terms, and measures to mitigate the harm from excessive terms. The TACD Press release follows:
The World Health Organization just published a report on this week’s second meeting of the WHO Expert Working Group (EWG) on R&D Financing.
Today nine NGOs sent a letter the WHO Expert Working Group on R&D Financing. The letter focuses on issues about transparency, conflicts of interest, and EWG outcomes. The whole EWG seems to be going very badly right now, in part because of the US government and much of Northern Europe is working hand and glove with the pharmaceutical industry, and partly because the Gates Foundation is protecting big pharma and seems to have an ideological attachment to strong IPR.
Apparently at least one entrant has qualified to win the $1 million Netflix grand prize. One can follow the progress of the teams on the Netflix Leaderboard: http://www.netflixprize.com/leaderboard.
According to Rapleaf CEO and venture capitalist Auren Hoffman, open source software has dramatically increased the productivity of software engineers. In a June 23, 2009 article in Tech Crunch titled “Engineers Are The Best Deal – So Stock Up On Them,” Hoffman writes:
The US Department of State “2009 Investment Climate Statement for Switzerland” provides an interesting and often unexpected portrait of the intellectual property landscape for a country that is often a hard-liner in global IPR negotiations. Continue Reading
The PAHO negotiations on the R&D resolution has produced a new draft, which radically guts the provision on transparency of pharmaceutical industry economics.
The US opposed this language:
“(j) to develop, with input from Member States, a possible standard for disclosure of economic data for drug registered for sale, including disclosures of the costs of R&D, the prices of products, and the annual revenues from the sale of products.”
The US agreed to this language:
Kira Alvarez is the Deputy Assistant USTR for Intellectual Property Enforcement, and the chief US negotiator for ACTA. According to her Linkedin bio, as late as October 2008, right before the election, she was the Time Warner Vice President for Global Public Policy, and before that, she was a lobbyist for Ely Lilly, the pharmaceutical company. Continue Reading